Effects of Nesfatin-1 on Food Intake and Hyperglycemia

References

• Yang M, Zhang Z, Wang C, Li K, Li S, Boden G, Li L, Yang G. Nesfatin-1 action in the brain increases insulin sensitivity through Akt/AMPK/TORC2 pathway in diet-induced insulin resistance. Diabetes 2012;61(8):1959–1968. doi: 10.2337/db11-1755.
   PubMed Web of Science ®Google Scholar
• Stengel A, Tache Y. Role of NUCB2/Nesfatin-1 in the hypothalamic control of energy homeostasis. Horm Metab Res. 2013;45(13):975–979. doi: 10.1055/s-0033-1351324.
   PubMed Web of Science ®Google Scholar
• Anwar GM, Yamamah G, Ibrahim A, El-Lebedy D, Farid TM, Mahmoud R. Nesfatin-1 in childhood and adolescent obesity and its association with food intake, body composition and insulin resistance. Regul Pept. 2014;188:21–24. doi: 10.1016/j.regpep.2013.12.001.
   PubMedGoogle Scholar
• Su Y, Zhang J, Tang Y, Bi F, Liu JN. The novel function of nesfatin-1: anti-hyperglycemia. Biochem Biophys Res Commun. 2010;391(1):1039–1042. doi: 10.1016/j.bbrc.2009.12.014.
   PubMed Web of Science ®Google Scholar
• Hofmann T, Stengel A, Ahnis A, Buße P, Elbelt U, Klapp BF. NUCB2/nesfatin-1 is associated with elevated scores of anxiety in female obese patients. Psychoneuroendocrinology 2013;38(11):2502–2510. doi: 10.1016/j.psyneuen.2013.05.013.
   PubMed Web of Science ®Google Scholar
• Chen X, Shu X, Cong ZK, Jiang ZY, Jiang H. Nesfatin-1 acts on the dopaminergic reward pathway to inhibit food intake. Neuropeptides 2015;5345–50. doi: 10.1016/j.npep.2015.07.004.
   PubMed Web of Science ®Google Scholar
• Shimizu H, Ohsaki A, Oh-I S, Okada S, Mori M. A new anorexigenic protein, nesfatin-1. Peptides 2009;30(5):995–998.
   PubMed Web of Science ®Google Scholar
• Khalili S, Shekari Khaniani M, Afkhami F, Mansoori Derakhshan S. NUCB2/Nesfatin-1: A Potent Meal Regulatory Hormone and its Role in Diabetes. Egypt J Med Human Genet. 2017;18(2):105–109. doi: 10.1016/j.ejmhg.2016.10.003.
   Google Scholar
• Mogharnasi M, TaheriChadorneshin H, Papoli-Baravati SA, Teymuri A. Effects of upper-body resistance exercise training on serum nesfatin-1 level, insulin resistance, and body composition in obese paraplegic men. Disabil Health J. 2019;12(1):29–34. doi: 10.1016/j.dhjo.2018.07.003.
   PubMed Web of Science ®Google Scholar
• Li Q-C, Wang H-Y, Chen X, Guan H-Z, Jiang Z-Y. Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul Pept. 2010;159(1–3):72–77. doi: 10.1016/j.regpep.2009.11.003.
   PubMedGoogle Scholar
• Stengel A. Nesfatin-1 - More than a food intake regulatory peptide. Peptides 2015;72175–183. doi: 10.1016/j.peptides.2015.06.002.
   PubMed Web of Science ®Google Scholar
• Stengel A, Goebel M, Tache Y. Nesfatin-1: a novel inhibitory regulator of food intake and body weight. Obes Rev. 2011;12(4):261–271. doi: 10.1111/j.1467-789X.2010.00770.x.
   PubMed Web of Science ®Google Scholar
• St-Pierre DH, Martin J, Shimizu H, Tagaya Y, Tsuchiya T, Marceau S, Biertho L, Bastien M, Caron-Cantin S-M, Simard S, et al. Association between nesfatin-1 levels and metabolic improvements in severely obese patients who underwent biliopancreatic derivation with duodenal switch. Peptides 2016;86:6–12. doi: 10.1016/j.peptides.2016.09.014.
   PubMed Web of Science ®Google Scholar
• Schalla MA, Stengel A. Current Understanding of the Role of Nesfatin-1. J Endocr Soc. 2018;2(10):1188–1206. doi: 10.1210/js.2018-00246.
   PubMed Web of Science ®Google Scholar
• Folgueira C, Seoane LM, Casanueva FF. The brain-stomach connection. Front Horm Res. 2014;42:83–92. doi: 10.1159/000358316.
   PubMed Web of Science ®Google Scholar
• Stengel A, Mori M, Tache Y. The role of nesfatin-1 in the regulation of food intake and body weight: recent developments and future endeavors. Obes Rev. 2013;14(11):859–870. doi: 10.1111/obr.12063.
   PubMed Web of Science ®Google Scholar
• Li Z, Gao L, Tang H, Yin Y, Xiang X, Li Y, Zhao J, Mulholland M, Zhang W. Peripheral effects of nesfatin-1 on glucose homeostasis. Plos One. 2013;8(8):e71513. doi: 10.1371/journal.pone.0071513.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Ma X, Wang Q, Zhou Y, Zhang Y, Wu L, Ji H, Qin G, Lu J, Bi Y, et al. Nesfatin-1 correlates with hypertension in overweight or obese Han Chinese population. Clin Exp Hypertens. 2015;37(1):51–56. doi: 10.3109/10641963.2014.897722.
   PubMed Web of Science ®Google Scholar
• Prinz P, Stengel A. Control of food intake by gastrointestinal peptides: mechanisms of action and possible modulation in the treatment of obesity. J Neurogastroenterol Motil. 2017;23(2):180–196. doi: 10.5056/jnm16194.
   PubMed Web of Science ®Google Scholar
• Stengel A, Goebel M, Wang L, Tache Y. Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: role as regulators of food intake and body weight. Peptides 2010;31(2):357–369. doi: 10.1016/j.peptides.2009.11.019.
   PubMed Web of Science ®Google Scholar
• Kovalyova O, Ashcheulova T, Demydenko A, Vizir M, Kochubiei O. Nesfatin-1 activity in patients with essential hypertension and prediabetes, type 2 diabetes. Georgian Med News. 2017;Feb(263):44–49.
   PubMedGoogle Scholar
• Ozkan Y, Timurkan ES, Aydin S, Sahin İ, Timurkan M, Citil C, Kalayci M, Yilmaz M, Aksoy A, Catak Z, et al. Acylated and desacylated ghrelin, preptin, leptin, and nesfatin-1 peptide changes related to the body mass index. Int J Endocrinol. 2013;2013:1. doi: 10.1155/2013/236085.
   Web of Science ®Google Scholar
• Abaci A, Catli G, Anik A, Kume T, Bober E. The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children. Pediatr Diabetes. 2013;14(3):189–195. doi: 10.1111/pedi.12009.
   PubMed Web of Science ®Google Scholar
• Mirzaei K, Hossein-Nezhad A, Keshavarz SA, Koohdani F, Eshraghian MR, Saboor-Yaraghi AA, et al. Association of nesfatin-1 level with body composition, dietary intake and resting metabolic rate in obese and morbid obese subjects. Diabetes Metab Syndr. 2015;9(4):292–298. doi: 10.1016/j.dsx.2014.04.010.
   PubMed Web of Science ®Google Scholar
• Prinz P, Stengel A. Expression and regulation of peripheral NUCB2/nesfatin-1. Curr Opin Pharmacol. 2016;31:25–30. doi: 10.1016/j.coph.2016.08.012.
   PubMed Web of Science ®Google Scholar
• Algul S, Ozkan Y, Ozcelik O. Serum nesfatin-1 levels in patients with different glucose tolerance levels. Physiol Res. 2016;65(6):979–985.
   PubMed Web of Science ®Google Scholar
• Zhang X, Qi J, Tang N, Wang S, Wu Y, Chen H, Tian Z, Wang B, Chen D, Li Z, et al. Intraperitoneal injection of nesfatin-1 primarily through the CCK-CCK1R signal pathway affects expression of appetite factors to inhibit the food intake of Siberian sturgeon (Acipenser baerii). Peptides 2018;109:14–22. doi: 10.1016/j.peptides.2018.09.008.
   PubMed Web of Science ®Google Scholar
• Stengel A, Tache Y. Nesfatin-1-role as possible new potent regulator of food intake. Regul Pept. 2010;163(1-3):18–23. doi: 10.1016/j.regpep.2010.05.002.
   PubMedGoogle Scholar
• Akın Ş, Ersöz NG, Aksoy DY, Karakaya J, Usman A. Increased serum nesfatin-1 levels in patients with impaired glucose tolerance. Turk J Endocrinol Metab. 2017;21:65–67. doi: 10.25179/tjem.2017-56543.
   Web of Science ®Google Scholar
• Akour A, Kasabri V, Boulatova N, Bustanji Y, Naffa R, Hyasat D, Khawaja N, Bustanji H, Zayed A, Momani M, et al. Levels of metabolic markers in drug-naive prediabetic and type 2 diabetic patients. Acta Diabetol. 2017;54(2):163–170. doi: 10.1007/s00592-016-0926-1.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Li L, Yang M, Liu H, Boden G, Yang G. Increased plasma levels of nesfatin-1 in patients with newly diagnosed type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2012;120(2):91–95. doi: 10.1055/s-0031-1286339.
   PubMed Web of Science ®Google Scholar
• Yan X, Zong W. Correlation analysis of serum Nesfatin-1, TNF-αand insulin resistance in patients with newly diagnosed type 2 diabetes. Chin J Diab. 2017;25(1):45–48.
   Google Scholar
• Fasshauer M, Blüher M. Adipokines in health and disease. Trends Pharmacol Sci. 2015;36(7):461–470. doi: 10.1016/j.tips.2015.04.014.
   PubMed Web of Science ®Google Scholar
• Prinz P, Stengel A. Nesfatin-1: current status as a peripheral hormone and future prospects. Curr Opin Pharmacol. 2016;3119–24. doi: 10.1016/j.coph.2016.08.011.
   PubMed Web of Science ®Google Scholar
• Vizir M, Kovalyova O. The role of nesfatin-1 in the development of insulin resistance in hypertensive patients. Arch Cardiovascul Diseases Suppl. 2018;10(1):111. doi: 10.1016/j.acvdsp.2017.11.228.
   Google Scholar